Practical Designs for Phase I Combination Studies in Oncology

Journal of Biopharmaceutical Statistics - United States
doi 10.1080/10543406.2015.1092029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Designs for Phase I Trials in Ordered Groups

Statistics in Medicine
EpidemiologyStatisticsProbability
2016English

Escalation Strategies for Combination Therapy Phase I Trials

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2012English

Change in Tumor Size by RECIST Correlates Linearly With Overall Survival in Phase I Oncology Studies

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Comments on ‘Competing Designs for Drug Combination in Phase I Dose-Finding Clinical Trials’ by M-K. Riviere, F. Dubois, S. Zohar

Statistics in Medicine
EpidemiologyStatisticsProbability
2014English

Sequential Designs for Phase I Clinical Trials With Late-Onset Toxicities

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2000English

First-In-Human Phase 1 Studies in Oncology: The New Challenge for Investigative Sites

Rambam Maimonides Medical Journal
Medicine
2012English

Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience

2010English

Accuracy, Safety, and Reliability of Novel Phase I Designs—Response

Clinical Cancer Research
Cancer ResearchOncology
2018English

Relationship Between Response and Dose in Published, Contemporary Phase I Oncology Trials

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy